Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adrian Merlo

Showing results (31-40 of 44) with videos related to

Pageof 5
Sort By:
The Journal of Clinical Investigation|January 10, 2014
MNK1 pathway activity maintains protein synthesis in rapalog-treated gliomasMichal Grzmil, Roland M Huber, Daniel Hess, et al.
Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics|January 6, 2009
Oral bacterial cultures in nontraumatic brain abscesses: results of a first-line studyAndreas Albert Mueller, Belma Saldamli, Stefan Stübinger, et al.
Seminars in Nuclear Medicine|March 17, 2020
<sup>225</sup>Ac- and <sup>213</sup>Bi-Substance P Analogues for Glioma TherapyLeszek Królicki, Jolanta Kunikowska, Frank Bruchertseifer, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 2, 2002
PET imaging drug distribution after intratumoral injection: the case for (124)I-iododeoxyuridine in malignant gliomasUlrich Roelcke, Oliver Hausmann, Adrian Merlo, et al.
Matrix Biology : Journal of the International Society for Matrix Biology|February 26, 2011
SMOC1 is a tenascin-C interacting protein over-expressed in brain tumorsFlorence Brellier, Sabrina Ruggiero, Daniela Zwolanek, et al.
European Journal of Nuclear Medicine and Molecular Imaging|December 1, 2018
Safety and efficacy of targeted alpha therapy with <sup>213</sup>Bi-DOTA-substance P in recurrent glioblastomaLeszek Królicki, Frank Bruchertseifer, Jolanta Kunikowska, et al.
European Journal of Nuclear Medicine and Molecular Imaging|May 2, 2018
Prolonged survival in secondary glioblastoma following local injection of targeted alpha therapy with <sup>213</sup>Bi-substance P analogueLeszek Krolicki, Frank Bruchertseifer, Jolanta Kunikowska, et al.
International Journal of Oncology|September 30, 2009
The 10q25.3-26.1 G protein-coupled receptor gene GPR26 is epigenetically silenced in human gliomasJean-Louis Boulay, Mihai-Constantin S Ionescu, Balasubramanian Sivasankaran, et al.
Genes, Chromosomes & Cancer|November 7, 2003
10q25.3 (DMBT1) copy number changes in astrocytoma grades II and IVPeter H Wessels, Albert Twijnstra, Bela Kubat, et al.
Plos One|June 28, 2007
Loss of NOTCH2 positively predicts survival in subgroups of human glial brain tumorsJean-Louis Boulay, André R Miserez, Christian Zweifel, et al.
Pageof 5

Showing results (31-40 of 44) with videos related to

Sort By:
Pageof 5
The Journal of Clinical Investigation|January 10, 2014
MNK1 pathway activity maintains protein synthesis in rapalog-treated gliomasMichal Grzmil, Roland M Huber, Daniel Hess, et al.
Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics|January 6, 2009
Oral bacterial cultures in nontraumatic brain abscesses: results of a first-line studyAndreas Albert Mueller, Belma Saldamli, Stefan Stübinger, et al.
Seminars in Nuclear Medicine|March 17, 2020
<sup>225</sup>Ac- and <sup>213</sup>Bi-Substance P Analogues for Glioma TherapyLeszek Królicki, Jolanta Kunikowska, Frank Bruchertseifer, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 2, 2002
PET imaging drug distribution after intratumoral injection: the case for (124)I-iododeoxyuridine in malignant gliomasUlrich Roelcke, Oliver Hausmann, Adrian Merlo, et al.
Matrix Biology : Journal of the International Society for Matrix Biology|February 26, 2011
SMOC1 is a tenascin-C interacting protein over-expressed in brain tumorsFlorence Brellier, Sabrina Ruggiero, Daniela Zwolanek, et al.
European Journal of Nuclear Medicine and Molecular Imaging|December 1, 2018
Safety and efficacy of targeted alpha therapy with <sup>213</sup>Bi-DOTA-substance P in recurrent glioblastomaLeszek Królicki, Frank Bruchertseifer, Jolanta Kunikowska, et al.
European Journal of Nuclear Medicine and Molecular Imaging|May 2, 2018
Prolonged survival in secondary glioblastoma following local injection of targeted alpha therapy with <sup>213</sup>Bi-substance P analogueLeszek Krolicki, Frank Bruchertseifer, Jolanta Kunikowska, et al.
International Journal of Oncology|September 30, 2009
The 10q25.3-26.1 G protein-coupled receptor gene GPR26 is epigenetically silenced in human gliomasJean-Louis Boulay, Mihai-Constantin S Ionescu, Balasubramanian Sivasankaran, et al.
Genes, Chromosomes & Cancer|November 7, 2003
10q25.3 (DMBT1) copy number changes in astrocytoma grades II and IVPeter H Wessels, Albert Twijnstra, Bela Kubat, et al.
Plos One|June 28, 2007
Loss of NOTCH2 positively predicts survival in subgroups of human glial brain tumorsJean-Louis Boulay, André R Miserez, Christian Zweifel, et al.
Pageof 5